Study of Glucose-6-Phosphate Dehydrogenase Deficiency in Azerbaijan Population
Article Sidebar
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Main Article Content
Abstract
G6PD deficiency anemia presented mainly with pallor, dark red urine and jaundice after exposure to certain diets, drugs and diseases and therefore patients with G6PD deficiency should avoid exposure to these precipitating factors of hemolysis. We can also recommend large neonatal screening programs to detect cases of G6PD deficiency before the occurrence of acute hemolysis and molecular studies to detect G6PD enzyme variant in Azerbaijan. Data were collected from patient's files, from November 2017 to November 2023, using the pre-designed questionnaires to obtain the complete history, clinical presentation and laboratory investigations including the complete blood count, red blood cells morphology, liver and renal functions and quantitative assay of G6PD enzyme activity by spectrophotometric method.
Article Details
References
Bienzle U, Effiong C, Luzzatto L. Erythrocyte glucose 6-phosphate dehydrogenase deficiency (G6PD type A-) and neonatal jaundice. Acta Paediatr Scand. (1976) 65:701–3. 63.
Olusanya BO, Emokpae AA, Zamora TG, Slusher TM. Addressing the burden of neonatal hyperbilirubinaemia in countries with significant glucose-6-phosphate dehydrogenase deficiency. Acta Paediatr. (2014) 103:1102–9.
Isa HM, Mohamed MS, Mohamed AM, Abdulla A, Abdulla F. Neonatal indirect hyperbilirubinemia and glucose-6-phosphate dehydrogenase deficiency. Korean J Pediatr. (2017) 60:106–11.
Aghayeva S.A., Huseynova L.S., Kichibekov B.R., Aliyeva K.A., Khalilov R.I. Inherited metabolic disease phenylketonuriya and deficiency of G6PD enzim in a family study. German Herald Science № 2. Germany. 2018., p 34-36.
Huseynova L.S., Mahmudova P.A. Identification of GALT gene mutations in the Azerbaijan population. 8th International Baskent Congress on Life, Engineering, and Applied Sciences. Humanities and Social Sciences / Medicine, Nursing, and health Sciences. Turkey. Ankara.2023. p.318-321.
Huseynova L.S. Newborn screening for Galaktosemia. 3rd International Acharaka Congress on Life, Engineering, and Applied Sciences. Turkey. Izmir. 2023. p.98-102.
Huseynova L.S., Mahmudova P.A. The importance of early molecular-genetic diagnosis in the treatment of galactosemia. Proceedings of the 3rd International Scientific and Practical Conference Scientific Paradigm in the context of technologies and society development. Geneva, Switzerland.2022. p.245-249.
Pearson HA. Life-span of the fetal red blood cell. J Pediatr. (1967) 70:166–71.
Zipursky A, Brown E, Palko J, Brown EJ. The erythrocyte differential count in newborn infants. Am J Pediatr Hematol Oncol. (1983) 5:45–51.
Listowsky I, Gatmaitan Z, Arias IM. Ligandin retains and albumin loses bilirubin binding capacity in liver cytosol. Proc Natl Acad Sci USA. (1978) 75:1213–6.
Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyl transferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology. (2002) 123:127–33.
Goldstein GW, Hammaker L, Schmid R. The catabolism of Heinz bodies: an experimental model demonstrating conversion to non-bilirubin catabolites. Blood. (1968) 31:388–95.
Azma RZ, Hidayati N, Farisah NR, Hamidah NH, Ainoon O. G6PD enzyme activity in normal term Malaysian neonates and adults using a OSMMR2000-D kit with Hb normalization. Southeast Asian J Trop Med Public Health. (2010) 41:982–8.
Bancone G, Gornsawun G, Chu CS, Porn P, Pal S, Bansil P, et al. Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood. PLoS One. (2018) 13:e0196716.
Pengboon P, Thamwarokun A, Changsri K, Kaset C, Chomean S. Evaluation of quantitative biosensor for glucose-6-phosphate dehydrogenase activity detection. PLoS One. (2019) 14:e0226927.
Yu F, Zhang S, Chen B, Zhou Y, Ma C, Yang S, et al. Evaluation of the diagnostic accuracy of the CareStart™ glucose-6-phosphate dehydrogenase deficiency rapid diagnostic test among Chinese newborns. J Trop Pediatr. (2020) 66:495–503.
Huseynova L.S., Ansarova A.H. Application of Sanger sequence technology in the study of CFTR, MEFV, GALT, PAH, BCKDHB and DBT gene mutations in the population Azerbaijan. International journal of online and biomedical engineering. Vol. 19, No. 01, Austria. 2023. P. 153-161